PLATO bleeding criteria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (9 intermediate revisions by 7 users not shown) | |||
| Line 1: | Line 1: | ||
{{ | __NOTOC__ | ||
{{Bleeding}} | |||
{{CMG}} | {{CMG}} | ||
==PLATO Bleeding Classification''' <ref name="pmid15842354">{{cite journal| author=Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis| title=Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. | journal=J Thromb Haemost | year= 2005 | volume= 3 | issue= 4 | pages= 692-4 | pmid=15842354 | doi=10.1111/j.1538-7836.2005.01204.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15842354 }}</ref>== | |||
PLATO | |||
<ref name="pmid15842354">{{cite journal| author=Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis| title=Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. | journal=J Thromb Haemost | year= 2005 | volume= 3 | issue= 4 | pages= 692-4 | pmid=15842354 | doi=10.1111/j.1538-7836.2005.01204.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15842354 }} </ref> | |||
{{cquote| | {{cquote| | ||
===1. Major Life-threatening:=== | |||
Fatal | *Fatal | ||
Intracranial | *[[Intracranial hemorrhage|Intracranial]] | ||
Intrapericardial with cardiac tamponade | *Intrapericardial with [[cardiac tamponade]] | ||
Resulting in hypovolemic shock or severe hypotension that requires pressors or surgery | *Resulting in [[hypovolemic shock]] or [[hypotension|severe hypotension]] that requires pressors or surgery | ||
Clinically overt or apparent bleeding associated with decrease in hemoglobin | *Clinically overt or apparent bleeding associated with decrease in [[hemoglobin]] >5 g/dL | ||
Requiring transfusion of | *Requiring transfusion of ≥4 U whole blood or PRBCs | ||
=====Other Major===== | |||
Significantly disabling (eg, intraocular with permanent vision loss) | *Significantly disabling (eg, intraocular with permanent vision loss) | ||
Associated drop in hemoglobin of 3 to 5 g/dL | *Associated drop in [[hemoglobin]] of 3 to 5 g/dL | ||
Requiring transfusion of 2 to 3 U whole blood or PRBCs | *Requiring transfusion of 2 to 3 U whole blood or PRBCs | ||
=====Any Major===== | |||
Any one of the above criteria | *Any one of the above criteria | ||
===2. Minor=== | |||
Requiring medical intervention to stop or treat bleeding ( | *Requiring medical intervention to stop or treat bleeding (e.g., [[epistaxis]] requiring visit to medical facility for packing) | ||
===3. Minimal=== | |||
All others ( | *All others (e.g., [[Bruise|bruising]], [[bleeding gums]], oozing from injection sites) not requiring intervention or treatment}} | ||
==References== | |||
{{ | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Medical emergencies]] | [[Category:Medical emergencies]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 23:44, 29 July 2020
|
Bleeding Microchapters |
|
Treatment |
|---|
|
Reversal of Anticoagulation and Antiplatelet in Active Bleed |
|
Perioperative Bleeding |
|
PLATO bleeding criteria On the Web |
|
American Roentgen Ray Society Images of PLATO bleeding criteria |
|
Risk calculators and risk factors for PLATO bleeding criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
PLATO Bleeding Classification [1]
| “ |
1. Major Life-threatening:
Other Major
Any Major
2. Minor
3. Minimal
|
” |
References
- ↑ Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005). "Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients". J Thromb Haemost. 3 (4): 692–4. doi:10.1111/j.1538-7836.2005.01204.x. PMID 15842354.